SAT-079-Respiratory infection in patients with cirrhosis and acute variceal bleeding on antibiotic prophylaxis: A multicenter observational study of 2138 patients

Javier Martinez, Tellez luis, Virginia Hernandez-Gea, Bogdan Procopet, Alvaro Giraldez-Gallego, Lucio Amitrano, Candid Villanueva, Dominique Thabut, Luis Ibañez, Gilberto Silva-Junior, Joan Genesca, Bureau christophe, Elba Llop, Wim Laleman, Jose María Palazon, José Castellote, Susana G. Rodrigues, Lise Lotte Gluud, Carlos Noronha Ferreira, Rafael BarceloNuria Cañete, Manuel Rodriguez, Prof. Dr. Arnulf Ferlitsch, Jose Luis Mundi, Henning Granbæk, Manuel Hernandez-Guerra, Romanno Sassatelli, Alessandra Dell'Era, Marco Senzolo, Juan Abraldes, Manolo Romero-gómez, Alexander Zipprich, Meritxell Casas, Helena Masnou, Massimo Primignani, Aleksander Krag, Frederik Nevens, José Luis Calleja Panero, Christian Jansen, Marie Angele Robic, Irene Conejo, Maria-Vega Catalina, Marika Rudler, Rafael Bañares, Edilmar Alvarado, Jonel Trebicka, Maria Anna Guardascione, Marcel Tantau, Ferran Torres, Jaime Bosch, Garcia Pagan Juan Carlos, Agustin Albillos

Research output: Contribution to journalArticleResearchpeer-review

Abstract

Background and aims: Antibiotic prophylaxis is recommended to reduce the high risk of bacterial infection in patients with acute variceal bleeding (AVB). The aim of this study was to evaluate the incidence and risk factors of bacterial infection in patients with AVB receiving antibiotic prophylaxis. Method(s): Sub-analysis of a multicenter, international, observational study of 2138 patients with cirrhosis admitted for AVB from October 2011 toMay 2015 to address the efficacy of pre-emptive TIPS. We excluded patients with infection at admission (368)and those who did not received antibiotic prophylaxis (114, 5%). Finally, 1656 patients were included in the analyses. Result(s): Third generation cephalosporins (1263 patients, 76.3%)and quinolones (308 patients, 18.6%)were the main antibiotics used for prophylaxis. Bacterial infection developed in 336 out of the 1656 patients (20%): respiratory (156 patients, 46%), urinary (52, 3%), bacteriemia (34, 10%), SBP (29, 9%), cellulitis (12, 3%), others (53, 16%)and unknown (30, 9%). We specifically analyzed the risk factors of respiratory infection, the most frequent infection observed. Patients that developed respiratory infection (n = 156; 9, 4%)were similar to non-infected patients (n = 1320)regarding etiology of cirrhosis (alcohol, 52 vs. 45%), Child (B/C, 51/30 vs. 52/24%), previous antibiotic use (12 vs. 11%). Respiratory infection rates were independent of the type of antibiotic prophylaxis. Differences between groups were associated with active alcohol abuse (44 vs. 34%; p = 0.01), oro-tracheal intubation (41 vs. 17%; p = 0.001), nasogastric tube (44 vs. 30%; p = 0.001), and balloon tamponade (8 vs. 2%; p = 0, 02). In multivariate analysis, active alcohol abuse (OR 1.7; 95%CI 1.4-2), nasogastric tube (OR 1.7; 95%CI 1.2-2.4), oro-tracheal intubation (OR 3.1; 95%CI 2.1-4.3)and balloon tamponade (OR 2.6; 95%CI 1.8-5.1)were independently associated with respiratory infection. Further, in multivariate analysis, oro-tracheal intubation (OR 1.5; 95%CI 1.1-2.1)and nasogastric tube (OR 1.3; 95%CI 1.0-1.7)were also independently associated with the development of any type of bacterial infection. Conclusion(s): Five percent of patients with AVB do not receive antibiotic prophylaxis. Respiratory infection is the most common bacterial infection in patients on antibiotic prophylaxis, and its risk factors are airway manipulation and active alcohol use. Current recommendations of antibiotic prophylaxis show rather low efficacy to prevent respiratory infection in patients with AVB at high-risk.Copyright © 2019 European Association for the Study of the Liver
Original languageEnglish
Pages (from-to)e663-e664
JournalJ. Hepatol.
Volume70
Issue number1
DOIs
Publication statusPublished - Apr 2019

Fingerprint

Dive into the research topics of 'SAT-079-Respiratory infection in patients with cirrhosis and acute variceal bleeding on antibiotic prophylaxis: A multicenter observational study of 2138 patients'. Together they form a unique fingerprint.

Cite this